A niche blog dedicated to the issues that arise when supplementary protection certificates (SPCs) extend patents beyond their normal life -- and to the respective positions of patent owners, investors, competitors and consumers. The blog also addresses wider issues that may be of interest or use to those involved in the extension of patent rights. You can email The SPC Blog here

Tuesday 24 June 2008

30 years on, EFPIA President sees SPC as a milestone

Medical News Today ("30 Years Contributing To The Health And Wealth Of EU Citizens") reports the speech given on the occasion of EFPIA's 30th anniversary Annual General Meeting by its President, Bayer HealthCare CEO Arthur J. Higgins. Calling a new spirit of cooperation and partnership between the pharmaceutical industry and the stakeholder community, Higgins cited the Innovative Medicines Initiative as a good example of partnership to accelerate the R&D of new medicines. Enumerating the EFPIA's achievements over the past three decades he specifically mentioned the Supplementary Protection Certificate, introduced in the early '90s to compensate for the long time required for marketing authorisation and providing up to five additional years of patent protection.

No comments: